IDEAS home Printed from https://ideas.repec.org/a/plo/pone00/0332906.html

The impact of ESG performance on corporate innovation—Empirical evidence from Chinese pharmaceutical listed companies

Author

Listed:
  • Liqiang Li
  • Su Wang
  • Yuwen Chen

Abstract

Environmental, social and governance performance is an important driver for companies to achieve innovative and high-quality development, and the relationship between sustainable development and corporate innovation is one of the key concerns of pharmaceutical companies. This study aims to reveal the intrinsic role mechanism of sustainable transformation of pharmaceutical enterprises in high-quality innovation development. Based on the relevant data of China’s A-share pharmaceutical listed companies from 2015 to 2022, the study establishes a fixed effect model and a mediation effect model, empirically examines the impact of ESG performance on the innovation of pharmaceutical listed companies, and deeply explores the role mechanism of R&D personnel investment and government subsidies in it. The study finds that: (1) ESG performance significantly enhances firms’ innovation inputs and green innovation outputs; (2) this facilitating effect is more substantial among non-state-owned firms and firms in the eastern region; (3) good ESG performance has a more pronounced facilitating effect on innovation inputs of large firms, while it has a more prominent effect on the green innovation outputs of small and medium-sized firms; and (4) the mechanism analysis indicates that internal R&D personnel investment and external government subsidies play a significant mediating effect between ESG performance and corporate innovation. This study provides new empirical evidence for understanding the mechanism of ESG performance on corporate innovation in Chinese pharmaceutical companies. It provides theoretical support for proactively promoting the sustainable transformation and deepening the development of green innovation in Chinese pharmaceutical companies. In addition, there are important policy implications for promoting the sustainable transformation of pharmaceutical companies: the establishment of differentiated ESG incentive policies, the improvement of R&D talent training mechanisms, and the optimization of government subsidy allocations, focusing on supporting green innovation by companies with excellent ESG performance.

Suggested Citation

  • Liqiang Li & Su Wang & Yuwen Chen, 2025. "The impact of ESG performance on corporate innovation—Empirical evidence from Chinese pharmaceutical listed companies," PLOS ONE, Public Library of Science, vol. 20(11), pages 1-23, November.
    • Handle: RePEc:plo:pone00:0332906
    DOI: 10.1371/journal.pone.0332906
    as

    Download full text from publisher

    File URL: https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0332906
    Download Restriction: no
    File URL: https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0332906&type=printable
    Download Restriction: no
    File URL: https://libkey.io/10.1371/journal.pone.0332906?utm_source=ideas
    LibKey link: if access is restricted and if your library uses this service, LibKey will redirect you to where you can use your library subscription to access this item
    ---><---

    References listed on IDEAS

    as
    1. Goretti Cabaleiro-Cerviño & Pedro Mendi, 2024. "ESG-driven innovation strategy and firm performance," Eurasian Business Review, Springer;Eurasia Business and Economics Society, vol. 14(1), pages 137-185, March.
    Full references (including those not matched with items on IDEAS)

    Most related items

    These are the items that most often cite the same works as this one and are cited by the same works as this one.
    1. Wang, AnChao & Saqib, Abdul, 2025. "How entrepreneurship drives ESG performance: The roles of data assetization and financing constraints," Finance Research Letters, Elsevier, vol. 82(C).
    2. Mathias Payer & Martin Schüder & Tanja Gemünden & Henning Zülch, 2025. "Aligning ESG ratings with cultural values: a framework for the German-speaking region," Sustainability Nexus Forum, Springer, vol. 33(1), pages 1-19, December.
    3. Lee, Chien-Chiang & Zhao, Ya-Nan, 2025. "What affects national innovative capacity? The role of economic growth and trade openness," Economic Analysis and Policy, Elsevier, vol. 86(C), pages 1099-1118.
    4. Ruizhen Li & Kanwal Zahra & Hina Najam & Saitao Jia, 2025. "Examining the role of digitalization and ESG strategies in enhancing resilience and sustainable performance of SMEs," International Entrepreneurship and Management Journal, Springer, vol. 21(1), pages 1-23, December.
    5. Jiajia Liao & Masooma Batool & Syed Jawad Ali Kazmi & Fengcun Feng & Abad Alzuman, 2025. "Studying the nexus of business analytics capabilities with ESG performance. How resource orchestration capabilities, organizational agility, and business model innovation bridge this relationship," International Entrepreneurship and Management Journal, Springer, vol. 21(1), pages 1-25, December.
    6. Ma, Yonghong & Zhu, Enjia, 2025. "Supply chain finance and enterprise dual innovation: The perspective of breakthrough and incremental innovation," International Review of Financial Analysis, Elsevier, vol. 105(C).
    7. Zhang, Xuehui & Mu, Guoying & Han, Fei, 2025. "The nonlinear impact of firms' ESG disclosures on analysts' earnings forecast accuracy," International Review of Financial Analysis, Elsevier, vol. 104(PA).
    8. Nghia Nguyen Trinh & Nghia Dang Nguyen, 2025. "Geopolitical Risk and Environmental, Social, and Governance (ESG) practices of listed companies in Vietnam," HO CHI MINH CITY OPEN UNIVERSITY JOURNAL OF SCIENCE - ECONOMICS AND BUSINESS ADMINISTRATION, HO CHI MINH CITY OPEN UNIVERSITY JOURNAL OF SCIENCE, HO CHI MINH CITY OPEN UNIVERSITY, vol. 15(5), pages 150-168.

    More about this item

    Statistics

    Access and download statistics

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:plo:pone00:0332906. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    If CitEc recognized a bibliographic reference but did not link an item in RePEc to it, you can help with this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: plosone (email available below). General contact details of provider: https://journals.plos.org/plosone/ .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.